Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141255 |
| CAS No | NA |
| Mol.F. | C10H12Cl3N3O |
| Mol.Wt. | 296.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141256 |
| CAS No | NA |
| Mol.F. | C10H12Cl3N3O |
| Mol.Wt. | 296.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141257 |
| CAS No | NA |
| Mol.F. | C10H11Cl3N4O2 |
| Mol.Wt. | 325.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141258 |
| CAS No | NA |
| Mol.F. | C11H16ClN3O2 |
| Mol.Wt. | 257.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141259 |
| CAS No | NA |
| Mol.F. | C23H26Cl2N4O3 |
| Mol.Wt. | 477.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141260 |
| CAS No | NA |
| Mol.F. | C23H26Cl2N4O4 |
| Mol.Wt. | 493.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141261 |
| CAS No | 14026-03-0 |
| Mol.F. | C6H12N2O |
| Mol.Wt. | 128.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141262 |
| CAS No | NA |
| Mol.F. | C14H15N3O4 |
| Mol.Wt. | 289.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141263 |
| CAS No | NA |
| Mol.F. | C9H5N3O |
| Mol.Wt. | 171.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141264 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O2 |
| Mol.Wt. | 275.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141265 |
| CAS No | NA |
| Mol.F. | C13H12ClN3O |
| Mol.Wt. | 261.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141266 |
| CAS No | 2512217-82-0 |
| Mol.F. | C15H17N3O4 |
| Mol.Wt. | 303.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141267 |
| CAS No | NA |
| Mol.F. | C8H5N2O4S : Na |
| Mol.Wt. | 225.2 : 23.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141268 |
| CAS No | 1000399-11-0 |
| Mol.F. | C8H5BrN2O |
| Mol.Wt. | 225.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141269 |
| CAS No | NA |
| Mol.F. | C13H11N3O3 |
| Mol.Wt. | 257.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141271 |
| CAS No | NA |
| Mol.F. | C13H14N4O3 |
| Mol.Wt. | 274.3 |
| INV STATUS | In Stock |